产品名称 | NebuSelect™ Recombinant Human CD160, hFc-tag |
---|---|
目录号 | NBL-242966 |
别名 | CD160; CD160;-BY55; BY55FLJ46513; NK1; NK28 |
外观 | see COA |
分子量 | |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | O95971-1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242966-100ug | 100ug | Inquire | Inquire | |
NBL-242966-1mg | 1mg | Inquire | Inquire | |
NBL-242966-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human CD160, hFc-tag
Catalog#:
NBL-242966
Description:
NebuSelect™ Recombinant Human CD160, hFc-tag(Cat#NBL-242966) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Gly25-Leu158.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 41.3 kDa. Due to glycosylation, the protein migrates to 50-60 kDa based on Bis-Tris PAGE result.
Target Name:
CD160; CD160;-BY55; BY55FLJ46513; NK1; NK28
Target Information:
CD160 (also Natural killer cell receptor BY55) is a 27 ‑ 30 kDa member of the Ig superfamily. In human, it is expressed principally on nonmyeloid hematopoietic cells. CD160 antigenis a receptor on immune cells capable to deliver stimulatory or inhibitory signals that regulate cell activation and differentiation. Exists as a GPI-anchored and as a transmembrane form, each likely initiating distinct signaling pathways via phosphoinositol 3-kinase in activated NK cells and via LCK and CD247/CD3 zeta chain in activated T cells.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.